Biochemistry

Edited by: Steve Bunk Richard D. Palmiter Jay C. Erickson, Kathy E. Clegg, Richard D. Palmiter, "Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y," Nature, 381:415-8, 1996. (Cited in more than 205 papers since publication) Comments by Richard D. Palmiter , Howard Hughes Medical Institute investigator and University of Washington biochemistry professor Ah, for an ideal scientific world. In it, researchers demonstrate that injection of a specific neuropept

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Steve Bunk


Richard D. Palmiter
Jay C. Erickson, Kathy E. Clegg, Richard D. Palmiter, "Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y," Nature, 381:415-8, 1996. (Cited in more than 205 papers since publication)

Comments by Richard D. Palmiter , Howard Hughes Medical Institute investigator and University of Washington biochemistry professor

Ah, for an ideal scientific world. In it, researchers demonstrate that injection of a specific neuropeptide into the brain stimulates feeding. So they develop a drug that blocks this peptide's activity. People take the drug, eat less, obesity is swept off its substantial feet, and the marketplace comes running.

But in the real world, that particular transmitter, called neuropeptide Y (NPY), is not so cooperative. Yes, it does stimulate feeding when injected into the brain, but what happens if NPY is deleted from mice? They'll stop feeding without the need of a blocking drug, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies